Kajian klinikal Kejang di Alabama
8 kajian untuk Kejang sedang mencari peserta di lokasi di Alabama.
Bandar di Alabama
Teks kajian rasmi (Bahasa Inggeris)
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- University of Alabama at Birmingham, Birmingham
Mengambil pesertaFasa 3
Umur 2 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT04462770Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Clinic for Neurology, Huntsville
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07594119Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES
- Sparks Center Office of Psychiatric Research, Birmingham
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 11 hingga 18 · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT05096273Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND
- University of Alabama at Birmingham, Birmingham
Mengambil pesertaKajian pemerhatianMenyebut bayaran untuk peserta
Umur 8 hingga 89 · Semua jantina · Dikemas kini 11 Jun 2026 · NCT06362161Retraining and Control Therapy (ReACT)- Adults
- University of Alabama at Birmingham, Birmingham
Mengambil peserta
Umur 19 ke atas · Semua jantina · Dikemas kini 11 Jun 2026 · NCT06570954Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- University of Alabama, Birmingham
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 9 Jun 2026 · NCT05135091Retraining and Control Therapy (ReACT) R33 Phase
- University of Alabama at Birmingham, Birmingham
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 11 hingga 18 · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06007053A Multi-site Feasibility Clinical Trial of Retraining and Control Therapy (ReACT), a Mind and Body Treatment for Pediatric Functional Seizures
- University of Alabama at Birmingham, Birmingham
Mengambil peserta
Umur 11 hingga 18 · Semua jantina · Dikemas kini 17 Mac 2026 · NCT05819268Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.